Taiwan
· Delayed Price · Currency is TWD Medeon Biodesign Company Description
Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in Taiwan and the United States.
The company focuses on developing devices for minimally invasive surgeries, such as Duett, a vascular graft system; ClickClean, a solution to view throughout laparoscopic surgeries; AbClose to prevent port site herniation caused by improper closure; UroCross, an expander system; PUMA, a solution to treat orthopedic extremity injuries; and Cross-Seal, a large-bore closure device.
It is involved in medical device contract manufacturing, equity investment and commerce of medical devices, manufacturing and sale of injection molding and components of medical devices.
Medeon Biodesign, Inc. was incorporated in 2012 and is headquartered in Taipei, Taiwan.
| Country | Taiwan |
| Founded | 2012 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 39 |
| CEO | Yue-Teh Jang |
Contact Details
Address: 116, HouGang Street Taipei, 11170 Taiwan | |
| Phone | 886 2 2881 6686 |
| Website | medeonbio.com |
Stock Details
| Ticker Symbol | 6499 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006499007 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Yue-Teh Jang Ph.D. | Chairman of the Board and GM |
| Dr. Jenny Chen | Vice President of Finance and Business Analysis, Head of Corporate Governance and Chief Financial Officer |
| Tori Lin | Senior Manager of Finance and Business Analysis and Accounting Officer |
| Dr. Yi-Ju Chen | Executive Vice President |
| Greta Chang | Executive Vice President |